ANTIBODY MANUFACTURING: MODERN BIOPHARMACEUTICAL PRODUCTION TECHNOLOGIES AND QUALITY CONTROL STRATEGIES

Abstract

In recent decades, antibodies—particularly monoclonal
antibodies (mAbs)—have emerged as one of the most important classes of
biopharmaceutical products used in the treatment of cancer, autoimmune disorders,
infectious diseases, and rare genetic conditions. Their rapid development has
fundamentally transformed modern medicine by enabling highly targeted
therapeutic approaches with improved efficacy and reduced systemic toxicity. As a
result, antibody manufacturing has become a central focus of the global
biopharmaceutical industry